Bepotastine Besilate Patent Expiration
Bepotastine Besilate was first introduced by Bausch And Lomb Inc
Bepotastine Besilate Patents
Given below is the list of patents protecting Bepotastine Besilate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Bepreve | US8784789 | Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
Jan 13, 2025
(Expired) | Bausch And Lomb Inc |
| Bepreve | US8877168 | Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
Jul 30, 2023
(Expired) | Bausch And Lomb Inc |
| Bepreve | US6780877 | Acid addition salt of optically active piperidine compound and process for preparing the same |
Sep 19, 2019
(Expired) | Bausch And Lomb Inc |
Bepotastine Besilate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List